Scott Moore explores China’s trajectory in the global biotechnology sector. When The us continues to be the dominant global player in developing and commercializing biotechnology for many years, China is determined to be a leading player in biotechnology and is also investing seriously from the sector. Moore argues that, though the U.S. is probab